| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 6.567 | 13.766 | 20.352 | 79.691 | 136.259 | 124.978 |
| Total Income - EUR | - | - | - | - | 6.567 | 13.766 | 20.352 | 79.691 | 136.259 | 128.565 |
| Total Expenses - EUR | - | - | - | - | 27 | 661 | 6.296 | 27.749 | 98.133 | 96.353 |
| Gross Profit/Loss - EUR | - | - | - | - | 6.540 | 13.105 | 14.056 | 51.942 | 38.126 | 32.212 |
| Net Profit/Loss - EUR | - | - | - | - | 6.343 | 12.719 | 13.401 | 49.552 | 36.968 | 28.485 |
| Employees | - | - | - | - | 0 | 0 | 0 | 0 | 1 | 1 |
Check the financial reports for the company - Xeno Medical Research S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 0 | 0 | 0 | 2.780 | 2.417 | 2.081 |
| Current Assets | - | - | - | - | 6.417 | 19.129 | 32.060 | 85.213 | 119.654 | 130.276 |
| Inventories | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | 0 | 113 | 295 | 52.877 | 31.875 | 38.233 |
| Cash | - | - | - | - | 6.417 | 19.017 | 31.765 | 32.336 | 87.779 | 92.044 |
| Shareholders Funds | - | - | - | - | 6.386 | 18.983 | 31.963 | 81.882 | 118.602 | 109.663 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 31 | 146 | 96 | 6.110 | 3.470 | 22.695 |
| Income in Advance | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8623 - 8623" | |||||||||
| CAEN Financial Year |
8623
|
|||||||||
Comments - Xeno Medical Research S.r.l.